The utility of magnetic resonance imaging and spectroscopy for predicting insignificant prostate cancer: an initial analysis. Academic Article uri icon

Overview

abstract

  • OBJECTIVE: To design new models that combine clinical variables and biopsy data with magnetic resonance imaging (MRI) and MR spectroscopic imaging (MRSI) data, and assess their value in predicting the probability of insignificant prostate cancer. PATIENTS AND METHODS: In all, 220 patients (cT stage T1c or T2a, prostate-specific antigen level <20 ng/mL, biopsy Gleason score 6) had MRI/MRSI before surgery and met the inclusion criteria for the study. The probability of insignificant cancer was recorded retrospectively and separately for MRI and combined MRI/MRSI on a 0-3 scale (0, definitely insignificant; - 3, definitely significant). Insignificant cancer was defined from surgical pathology as organ-confined cancer of

publication date

  • January 12, 2007

Research

keywords

  • Magnetic Resonance Imaging
  • Magnetic Resonance Spectroscopy
  • Prostatic Neoplasms

Identity

Scopus Document Identifier

  • 33947304021

Digital Object Identifier (DOI)

  • 10.1111/j.1464-410X.2007.06689.x

PubMed ID

  • 17223922

Additional Document Info

volume

  • 99

issue

  • 4